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Abstract – The δ and γ subunits of the cGMP-phosphodiesterase (PDE6D, PDE6G) genes
were screened in order to identify mutations causing generalised progressive retinal atrophy
(gPRA) in dogs. In the PDE6D gene, single nucleotide polymorphisms (SNP) were observed
in exon 4, in introns 2 and 3 and in the 3′ untranslated region (UTR) of different dog breeds.
In the coding region of the PDE6G gene, exclusively healthy Labrador Retrievers showed an
A→ G transition in exon 4 without amino acid exchange. SNP were also observed in introns 1
and 2 in different dog breeds. The different SNP were used as intragenic markers to investigate
the involvement of both genes in gPRA. The informative substitutions allowed us to exclude
mutations in the PDE6D and PDE6G genes as causing retinal degeneration in 15 of the 22 dog
breeds with presumed autosomal recessively transmitted (ar) gPRA.
cGMP-phosphodiesterase / canine / generalised progressive retinal atrophy / SNP / retinitis
pigmentosa / SSCP
1. INTRODUCTION
Rod cGMP-phosphodiesterase (PDE) is the G-protein-activated effector
enzyme that regulates the level of cGMP in vertebrate photoreceptor cells [3,
13]. Rod cGMP PDE is generally viewed as a protein composed of catalytic
α and β subunits, two identical inhibitory γ subunits [30] and a δ subunit.
Respective DNA sequences were recently identified in men, mice, cows and
dogs [15,20,21]. The exact function of the δ subunit is still not known, since in
vitro it does not affect the catalytic activity of PDE. Loss of γ subunits entails
reduced hydrolytic activity and leads to an increased PDE activity [32].
Defects in genes encoding PDE subunits have been associated with retinal
disease in humans and several animal models [5,6,16,20,22,26,31,32]. For
autosomal recessively transmitted (ar), generalised progressive retinal atrophy
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(gPRA), the most common hereditary form in dogs, mutations have been identi-
fied in the β subunit of the PDE (PDE6B) gene in Irish Setters and Sloughis [12,
31] and in the α subunit (PDE6A) gene in Cardigan Welsh Corgis [25].
Retinitis pigmentosa (RP) in man is the homologous disease to gPRA in
dogs. Ar transmitted forms of RP have been mapped to the δ subunit (PDE6D;
2q35–36; RP26) and to the γ subunit genes in man (PDE6G; 17q25 RP17;
RetNet: http://www.sph.uth.tmc.edu/Retnet/). On the basis of reciprocal chro-
mosome painting the canine PDE6D gene is, therefore, predicted to map to
CFA 25 [7] and the PDE6G gene to CFA 9 [36], the homologous chromosomal
regions in dogs. These genes were recently excluded for rod-cone dysplasia 2
(rcd2) in collies [34], but mutations in these genes could cause gPRA in other
breeds. Therefore, these genes were investigated as candidate genes for gPRA
in 22 different breeds including gPRA affected dogs.
2. MATERIALS AND METHODS
2.1. Animals
The blood of 808 dogs from 22 different breeds including 114 gPRA-affected
animals (see Tab. I) was received from the owners in cooperation with breeding
organisations. The blood of most dogs was obtained from different regions
of Germany. In addition, several Saarloos Wolfdogs (Sa), Schapendoes (SD),
Sloughi (Sl) and Tibetan Terriers (TT) originated from the Netherlands (Sa,
SD), Switzerland (Sl, TT), Sweden (Sl) and the USA (Sl). By observing the
cases of PRA in the pedigrees, the breeders have assumed ar inheritance in the
following breeds (personal communications): Australian Cattle Dog, Collie,
Dachshund, Engl. Cocker Spaniel, Entlebuch Cattledog, Irish Setter, Labrador
Retriever, Miniature Poodle, Saarloos Wolfdog, Schapendoes, Sloughi and
Tibetan Terrier. Experienced veterinarians confirmed the gPRA status of
affected and unaffected dogs by ophthalmoscopy.
2.2. Isolation of DNA and polymerase chain reaction (PCR)
DNA was extracted from the peripheral blood according to standard pro-
tocols [23]. Genomic DNA from each affected dog as well as representative
healthy dogs and obligatory carriers was screened for mutations. Parts of
the PDE6D and PDE6G genes were amplified by PCR in a thermocycler
(Biometra, Goettingen, Germany). PCR were performed in 96-well microtiter
plates (Thermowell Costar Corning, NY). Each well contained 50 ng DNA
in a 10 µL reaction volume 100 mM Tris (pH 8.3), 500 mM KCl, 1 U Taq
Polymerase (Genecraft, Münster, Germany), 0.2 mM of each dNTP, 0.4 mM
of each primer and varying concentrations of MgCl2 (see Tab. II). For SSCP
analysis, 0.06 µL of [α32P] dCTP (10 mCi ·mL−1) was included in the PCR.
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Australian Cattle Dog (AC) 2 gPRA-affected late a 10
19 normal 2–4
Pyrenean Sheepdog (BDP) 1 gPRA-affected mid-onset b 5
42 normal 1–10
Bernese Mountain Dog (BMD) 1 gPRA-affected late b 10
Bolognese (Bo) 1 gPRA-affected late b 9
Collie (Co) 3 gPRA-affected early cd 4–8
1 normal 8
Dachshund (wire; D) 20 gPRA-affected variable b 1–13
49 normal 6–13
English Cocker Spaniel (ECS) 6 gPRA-affected late cd 3–11
6 normal 6–14
Entlebuch Cattledog (EC) 17 gPRA-affected late e 5–13
10 normal 1–7
Golden Retriever (GR) 2 gPRA-affected late b 5–10
8 normal 3–6
Irish Setter (IRS) 2 gPRA-affected early cd/late b 0.6–7
1 normal 3–13
Labrador Retriever (LR) 5 gPRA-affected late cd 8–12
139 normal 3–13
Miniature Poodle (MP) 28 gPRA-affected late cd 5–12
15 normal 1–12
Newfoundland (NF) 1 gPRA-affected mid-onset b 3
Polish Lowland Sheepdog (PON) 1 gPRA-affected late b 9
Rottweiler (Ro) 1 gPRA-affected late b 3
Saarloos Wolfdog (Sa) 7 gPRA-affected late b 7–9
118 normal 2–10
Scottish Terrier (ScT) 1 gPRA-affected late b 6
Schapendoes (SD) 3 gPRA-affected early d 2–6
7 normal 3–6
Sloughi (Sl) 5 gPRA-affected mid-onset b 2
183 normal 0.1–12
Tibetan Mastiff (TM) 2 gPRA-affected
1 normal
Tibetan Terrier (TT) 3 gPRA-affected mid-onset cd 7–8
93 normal 2–10
a [19]; b owners report/certificate of eye examination; c classifications of the different
onset forms of gPRA in the reviews ([9] and [24]); d online information among PRA
Today (http://www.sheepdog.com/diseases/pra/clinical); e [29]; f at the time when
blood was taken for DNA analysis.
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For genomic mutation analysis the following PCR procedure was applied:
an initial denaturation step (5 min at 95 ◦C), 10 initial cycles 1 ◦C above the
annealing temperature (see Tab. II), 22–25 cycles of 95 ◦C (30 s), annealing
temperature (30 s), elongation at 72 ◦C (30 s) and a final elongation step at
72 ◦C (3 min).
2.3. Cloning and identification of exon/intron junctions of intron 1
of the PDE6D gene
Parts of the PDE6D gene were cloned from a genomic canine λ-DNA library
(λ FIX®II Library; host: E. coli XL1-Blu MRA (P2) Stratagene, La Jolla, CA,
USA) according to the Stratagene standard protocol. Recombinant λ DNA was
fixed to HybondTM-N Nylon membranes (Amersham, Buckinghamshire, UK)
and UV-crosslinked (1′ 70 mJ · cm−2). The library was screened using PCR
amplificates from exon 2 corresponding to nucleotide positions 109–321 of the
canine PDE6D gene (EMBL accession number AF113996). These probes were
labelled using [α32P] dATP and the Megaprime Labelling System (Amersham,
Buckinghamshire, UK). Hybridisations were performed as described [8] and
hybridising clones were isolated and plaque purified [28]. Exon 1 of the PDE6D
gene was not identified in the clones. To search for sequences of intron 1 of the
PDE6D gene, the isolated λ clones were digested with HindIII and subcloned
in pBluescript®II+ phagemid (Stratagene, La Jolla; [27]). Parts of the cloned
intron 1 were amplified by PCR using the T7 primer (for the λ phage) and
an exonic primer specific for exon 2 in order to characterize the intron-exon
boundary of the PDE6D gene (EMBL accession number AJ427396). For
annealing temperatures see Table II. Long-range PCR using the Elongase
enzyme mix (GIBCO BRL, Karlsruhe, Germany) was performed from gen-
omic DNA in order to identify the splice donor site of intron 1 according
to the recommendations of the manufacturer. Sequencing reactions of 2–3
clones including exon 2, introns 1 and 2 were carried out by the dideoxy-chain
termination method using the Big Dye Terminator (Perkin-Elmer, Norwalk, CT,
USA) according to the manufacturer’s instructions. All sequencing reactions
were run on an automated DNA sequencer (Applied Biosystems 373 XL, Foster
City, USA) and analysed using the corresponding software.
2.4. PCR-SSCP and DNA sequence analyses of the PDE6D
and PDE6G genes
Primers were created for mutation screening of intron 1 after DNA sequence
analysis of the genomic PDE6D clones and genomic sequences of the PDE6D
and PDE6G genes (CF49360; see Tab. II). SSCP samples were treated as
described [10,11]. PCR products were digested dependent on the lengths of the
fragments [17] with different restriction enzymes (see Tab. II). The sequence
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variations in the PDE6D gene were investigated in intron 3 (with MnlI; XmaI)
and exon 5 (with HaeIII) using restriction fragment length polymorphism
(RFLP) analysis. Three µL of the PCR were denatured with 7 µL of loading
buffer (95% deionised formamide 10 mM NaOH, 20 mM EDTA, 0.06% (w/v)
xylene cyanol, and 0.06% (w/v) bromophenol blue). The samples were heated
to 95 ◦C for 5 min and snap cooled on ice. Three µL aliquots of the single-
stranded fragments were separated through two sets of 6% polyacrylamide
(acrylamide/bisacrylamide: 19/1) gels, one set containing 10% glycerol, and
the other containing 5% glycerol and 1 M urea. The gels were run with 1X
TBE buffer at 50–55 W for 4–6 h at 4 ◦C. All gels were dried and subjected to
autoradiography over night. All DNA samples with band shifts evidenced by
SSCP electrophoresis were purified and cycle sequenced as described above.
3. RESULTS AND DISCUSSION
3.1. Identification of intron 1 in the canine PDE6D gene
It was demonstrated that the human PDE6D gene comprises five exons [21]
vs. four exons in dogs [35]. Since the described “exon 1” of the PDE6D
gene of dogs could not be amplified from genomic DNA, an additional intron
was also assumed in dogs. Therefore, three genomic DNA clones with parts
of the PDE6D gene were isolated from a λ-DNA library. Yet the 5′ part of
“exon 1” was always lacking in these clones. Comparisons with the recently
published human genomic DNA (EMBL accession number AC073476) showed
an intron 1 size of 41 877 base pairs (bp). Therefore, the canine intron 1 may
well exceed clonable sizes in λ-phages. Also, the exact size of intron 1 could
not be determined via long range PCR of genomic DNA. Parts of intron 1
were sequenced after subcloning of the inserts of the λ-phages and PCR (splice
acceptor site intron1/exon2: atatttgatcagAAATTGGATGAA).
3.2. Mutation analysis
All coding exons of the PDE6D and PDE6G genes were investigated by
PCR-SSCP analysis including splice donor and acceptor sites as well as
adjacent intronic sequences except for 20 bp (primer sequence) of exon 1
and the splice donor site of intron 1 in the PDE6D gene. The DNA of
22 dog breeds including 114 gPRA-affected animals are covered in this
study. For six of these breeds either the causative gPRA mutations (Irish
Setter [31], and Sloughi [12]) or linked markers for the progressive rod cone
degeneration (prcd) form of gPRA are already known (Australian Cattle Dog,
English Cocker Spaniel, Labrador Retriever, Miniature Poodle; patented by
OptiGen, USA). The PDE6G gene is located near the prcd region, but is
excluded as a cause for RP 17 in man [4], the homologous gPRA form in these
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breeds [1]. The other 16 dog breeds were included in the analysis, because
all polymorphisms identified in these six breeds could then be excluded as a
causative mutation for gPRA in the remaining breeds. A second gPRA form
may exist in Irish Setters since one affected Setter showed late manifestation
of gPRA symptoms without the typical PDE6B mutation. Because of similar
phenotypic heterogeneity also in Miniature poodles, two forms of gPRA are
possible (see http://www.optigen.com).
3.2.1. PDE6D gene
In the coding region of the PDE6D gene, no polymorphisms were identified.
To identify intragenic SNP markers for the exclusion of the PDE6D gene
as a cause for gPRA, the 3′ UTR and intron 3 were screened completely.
Sequencing of the canine PDE6D gene revealed several differences to the
published data [35]: in intron 3 five exchanges and in the 3′UTR a single
sequence variation were identified in all genomic DNA. Furthermore SNP
were observed in intron 2 (874A→ T), 3 (1808A→ G; 2166T→ A) and the
untranslated exon 5 (4439C→ T; 4483T→ C; 4664C→ T) of different dog
breeds in the PDE6D gene (Tab. III).








PDE6D b Intron 2 847A→ T – LR, NF
PDE6D Intron 3 1808A→ G – Bo, BMD, Co, EC, LR,
MP, NF, Ro, Sa, SD
2166T→ A – BMD, EC, LR, Ro
PDE6D 3′UTR Exon 5 4439C→ T – SD
4483T→ C – AC, BMD, Co, ECS,
EC, LR, MP, Ro, Sl
4664C→ T – AC, D, Co, ECS, EC,
IRS, LR, MP, Ro, SD, Sl
PDE6G c Intron 1 744G→ A – AC, BMD, Co, D, ECS,
EC, GR, IRS, LR, MP,
Ro, Sa, ScT, SD, TT
PDE6G Intron 2 1662C→ T – ECS, EC, LR, Sa, SD
1694G→ A – ECS, EC, LR, Sa, SD
PDE6G Exon 4 2285G→ A (L78L) (LR) ∗
a For abbreviations see Table I; b position of SNP of the PDE6D gene refer to EMBL
accession number AJ427396; c SNP of the PDE6G gene refer to EMBL accession
number CF49360; ∗ heterozygous sequence variation in healthy Labrador Retrievers.
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3.2.2. PDE6G gene
In the coding region of the PDE6G gene (exon 4) a “silent”sequence variation
was identified at position 2285 (G→ A) in healthy Labrador retrievers. The
additional PCR-SSCP analysis of the complete 5′UTR, parts of the 3′UTR and
the two introns revealed informative SNP in intron 1, (position 744, G→ A)
and in intron 2 (position 1662; C→ T; position 1694, G→ A; see Tab. III).
3.3. Exclusion of PDE6D and PDE6G genes for ar transmitted gPRA
The identified intronic SNP were found in the heterozygous and homozygous
states in gPRA affected and unaffected dogs of different breeds (see Tab. III).
The breeding history, small population sizes and gPRA abundance in the
investigated breeds point together to a few meiotic events in which intragenic
recombinations could have occurred between any unidentified mutation in the
PDE6 loci and the SNP investigated here. Although the complete promoters
and all introns of the PDE6D and PDE6G genes could not be included in the
SSCP analyses, the observed sequence variations can be used as intragenic
markers for excluding the PDE6D and PDE6G genes as causing the ar trans-
mitted eye disease. gPRA is most commonly inherited as an ar transmitted trait
although in two dog breeds it is sex linked (Samojed and Siberian Husky [2])
and in one there is autosomal dominant (Mastiff) inheritance [18]. By assuming
ar inheritance, we excluded PDE6D as a candidate gene for gPRA via intragenic
SNP in 15 breeds: Australian Cattle Dog, Bernese Mountain Dog, Bolognese,
Collie, Entlebuch Cattledog, Dachshund, English Cocker Spaniel, Irish Setter,
Labrador Retriever, Miniature Poodle, Newfoundland, Rottweiler, Saarloos
Wolfdog, Schapendoes and Sloughi. Similarly, in 15 breeds the PDE6G gene
was excluded for the assumed ar gPRA in the Australian Cattle Dog, Bernese
Mountain Dog, Collie, Dachshund, English Cocker Spaniel, Entlebuch Cattle-
dog, Golden Retriever, Irish Setter, Labrador Retriever, Miniature Poodle, Rot-
tweiler, Saarloos Wolfdog, Scottish Terrier, Schapendoes and Tibetan Terrier.
Some dog breeds are only represented by one gPRA affected individual (Tab. I).
For these breeds the exclusion of the PDE6D and PDE6G genes is not definitive,
since the possibility of false clinical diagnosis is not ruled out completely. For-
tunately, the identified SNP in the PDE6D and PDE6G genes occurred in sev-
eral breeds. Therefore, it is possible to use these markers in further studies [33].
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